Article
Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion
2021-09-06
Abstract excerpt
Bladder cancer (BC) management demands the introduction of novel molecular targets for precision medicine. Cell surface glycoprotein CD44 has been widely studied as a potential biomarker of BC aggressiveness and cancer stem cells. However, significant alternative splicing and multiple glycosylation generate a myriad of glycoproteoforms with potentially distinct functional roles. The lack of tools for precise molec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d7ad7a1f-fc06-5afe-b380-78221dde17f1
- DOI
- 10.1101/2021.09.04.458979
